Souhaitez-vous accéder aux communiqués récents ?

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Biogen (BIIB) To Contact Him Directly To Discuss Their Options If you are a long-term...

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Quantum Technology Market by Computing, Communications, Imaging, Security, Sensing, Modeling and Simulation 2025 - 2035" report has been added to ...

FullThrottle Technologies, LLC, the company behind the industry’s most powerful first-party data platform announces its inclusion in the 2025 Inc. 5000.

Stream Companies, a full-service, fully integrated, tech-enabled advertising agency, announces it's placement on the Inc. 5000 for the 18th time this year.

Delray Beach, FL, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a...

– Global, pivotal Phase 3 study will evaluate efficacy and safety of zorevunersen compared to sham over a 52-week treatment period – – Dravet syndrome is a rare genetic disease characterized by...

CAMBRIDGE, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment...

ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition...

TOKYO and CAMBRIDGE, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...

CAMBRIDGE, Mass., July 25, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...